212 related articles for article (PubMed ID: 17277077)
1. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
Urushitani M; Ezzi SA; Julien JP
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
Gros-Louis F; Soucy G; Larivière R; Julien JP
J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
[TBL] [Abstract][Full Text] [Related]
3. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
4. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
6. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
Chritin M; Savasta M; Besson G
Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
[TBL] [Abstract][Full Text] [Related]
7. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
Chen R; Ende N
J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
[TBL] [Abstract][Full Text] [Related]
8. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
Gomes C; Keller S; Altevogt P; Costa J
Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
[TBL] [Abstract][Full Text] [Related]
9. [Implications of successful immunotherapy in ALS model mice].
Urushitani M
Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.
Takeuchi S; Fujiwara N; Ido A; Oono M; Takeuchi Y; Tateno M; Suzuki K; Takahashi R; Tooyama I; Taniguchi N; Julien JP; Urushitani M
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1044-56. PubMed ID: 20838241
[TBL] [Abstract][Full Text] [Related]
11. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
[TBL] [Abstract][Full Text] [Related]
13. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
Liu D; Bao F; Wen J; Liu J
Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
15. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
[TBL] [Abstract][Full Text] [Related]
16. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
17. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
[TBL] [Abstract][Full Text] [Related]
19. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.
Maier M; Welt T; Wirth F; Montrasio F; Preisig D; McAfoose J; Vieira FG; Kulic L; Späni C; Stehle T; Perrin S; Weber M; Hock C; Nitsch RM; Grimm J
Sci Transl Med; 2018 Dec; 10(470):. PubMed ID: 30518612
[TBL] [Abstract][Full Text] [Related]
20. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.
Ralph GS; Radcliffe PA; Day DM; Carthy JM; Leroux MA; Lee DC; Wong LF; Bilsland LG; Greensmith L; Kingsman SM; Mitrophanous KA; Mazarakis ND; Azzouz M
Nat Med; 2005 Apr; 11(4):429-33. PubMed ID: 15768029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
